Almotriptan

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 277 publications

Correction: In Vivo Evaluation of Almotriptan Malate Formulation Through Intranasal Route for the Treatment of Migraine: Systematic Development and Pharmacokinetic Assessment.

Correction: In Vivo Evaluation of Almotriptan Malate Formulation Through Intranasal Route for the Treatment of Migraine: Systematic Development and Pharmacokinetic Assessment.

Journal: AAPS PharmSciTech

Published: August 19, 2025

A Pharmacovigilance Study from 2004 to 2024 Utilizing the FDA Adverse Event Reporting System (FAERS) Examines Ischemic Adverse Events Linked to Triptan Use in Migraine Therapy.

A Pharmacovigilance Study from 2004 to 2024 Utilizing the FDA Adverse Event Reporting System (FAERS) Examines Ischemic Adverse Events Linked to Triptan Use in Migraine Therapy.

Journal: Journal of pain research

Published: July 04, 2025

Evaluating the association between migraine treatments and tinnitus: Insights from the US Food and Drug Administration adverse event reporting system.

Evaluating the association between migraine treatments and tinnitus: Insights from the US Food and Drug Administration adverse event reporting system.

Journal: PloS one

Published: June 09, 2025

Evaluating Triptan Safety in Pediatric Migraine Management: A Comprehensive Pharmacovigilance Analysis.

Evaluating Triptan Safety in Pediatric Migraine Management: A Comprehensive Pharmacovigilance Analysis.

Journal: Journal of pain research

Published: March 06, 2025

The impact of headache specialist density and the introduction of gepants and lasmitidan on prescriptions for acute migraine treatments: a regression and interrupted time series analysis.

The impact of headache specialist density and the introduction of gepants and lasmitidan on prescriptions for acute migraine treatments: a regression and interrupted time series analysis.

Journal: Frontiers in neurology

Published: November 19, 2024

Rizatriptan as an Over-the-Counter Triptan in the Treatment of Migraine Attacks.

Rizatriptan as an Over-the-Counter Triptan in the Treatment of Migraine Attacks.

Journal: Pain and therapy

Published: May 12, 2024

Recent Development of Zolmitriptan Formulation in Migraine Therapy: Production, Metabolism and Pharmaceutical Aspects.

Recent Development of Zolmitriptan Formulation in Migraine Therapy: Production, Metabolism and Pharmaceutical Aspects.

Journal: CNS & neurological disorders drug targets

Published: April 05, 2024

The putative proton-coupled organic cation antiporter is involved in uptake of triptans into human brain capillary endothelial cells.

The putative proton-coupled organic cation antiporter is involved in uptake of triptans into human brain capillary endothelial cells.

Journal: Fluids and barriers of the CNS

Published: March 13, 2024

The 5-HT1B and 5-HT1D agonists in acute migraine therapy: Ergotamine, dihydroergotamine, and the triptans.

The 5-HT1B and 5-HT1D agonists in acute migraine therapy: Ergotamine, dihydroergotamine, and the triptans.

Journal: Handbook of clinical neurology

Published: February 02, 2024

QuEChERS-assisted ion pair chromatography/fluorescence detection method for determination of antimigraine combination therapy in rabbit plasma samples: Application to a pharmacokinetic study.

QuEChERS-assisted ion pair chromatography/fluorescence detection method for determination of antimigraine combination therapy in rabbit plasma samples: Application to a pharmacokinetic study.

Journal: Journal of pharmaceutical and biomedical analysis

Published: June 07, 2023

Comparison table: Triptans.

Comparison table: Triptans.

Journal: The Medical letter on drugs and therapeutics

Published: June 02, 2023

Drugs for migraine.

Drugs for migraine.

Journal: The Medical letter on drugs and therapeutics

Published: June 02, 2023

Showing 1-12 of 277

Last Updated: 04/28/2026